Oxidative Stress in SLE T Cells, Is NRF2 Really the Target to Treat?
Open accessAbstract
Oxidative stress is a major component of cellular damage in T cells from patients with systemic lupus erythematosus (SLE) resulting amongst others in the generation of pathogenic Th17 cells. The NRF2/Keap1 pathway is the most important antioxidant system protecting cells from damage due to oxidative stress. Activation of NRF2 therefore seems to represent a putative therapeutic target in SLE, which is nevertheless challenged by several findings suggesting tissue and cell specific differences in the effect of NRF2 expression. This review focusses on the current understanding of oxidative stress in SLE T cells and its pathophysiologic and therapeutic implications.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AhR ligands can also signal through Nrf2, a pleiotropic transcription factor involved in redox homeostasis, metabolism, and immune modulation.
“AhR ligands can also signal via Nuclear factor erythroid 2-related factor 2 (Nrf2)48–51, a pleiotropic transcription factor involved in redox homeostasis, metabolism, and immune modulation52.”
From Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy (2025) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Tsokos, G. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990 · see citing works
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · see citing works
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,747 · see citing works
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878 · see citing works
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · see citing works
Sena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338 · see citing works
Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis
Li, W., Khor, T. O., Xu, C., Shen, G., Jeong, W.-S., Yu, S., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.017 · Cited by 738 · see citing works
Maj, T., Wang, W., Crespo, J., Zhang, H., Wang, W., Wei, S., Zhao, L., Vatan, L., Shao, I., Szeliga, W., et al. (2017) · Nature Immunology · doi:10.1038/ni.3868 · Cited by 733 · see citing works
The role of defective clearance of apoptotic cells in systemic autoimmunity
Munoz, L. E., Lauber, K., Schiller, M. R., Manfredi, A. A., & i, M. H. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.46 · Cited by 625 · see citing works
Disruption of <i>Nrf2</i> enhances susceptibility to severe airway inflammation and asthma in mice
Rangasamy, T., Guo, J., Mitzner, W. A., Roman, J., Singh, A., Fryer, A. D., Yamamoto, M., Kensler, T. W., Tuder, R. M., Georas, S. N., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050538 · Cited by 580 · see citing works
Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium–Induced Colitis
Khor, T. O., Huang, M., Kwon, K. H., Chan, J. Y., Reddy, B. S., & Kong, A. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3562 · Cited by 530 · see citing works
Glutathione primes t cell metabolism for inflammation
Mak, T. W., Grusdat, M., Duncan, G. S., Dostert, C., Nonnenmacher, Y., Cox, M., Binsfeld, C., Hao, Z., Brüstle, A., Itsumi, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.019 · Cited by 511 · see citing works
Lai, Z., Hanczko, R., Bonilla, E., Caza, T. N., Clair, B., Bartos, A., Miklossy, G., Jimah, J., Doherty, E., Tily, H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34502 · Cited by 428 · see citing works
Oxidative stress in the pathology and treatment of systemic lupus erythematosus
Perl, A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.147 · Cited by 358 · see citing works
Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide
Thimmulappa, R. K., Scollick, C., Traore, K., Yates, M. S., Trush, M. A., Liby, K. T., Sporn, M. B., Yamamoto, M. P., Kensler, T. W., & Biswal, S. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.102 · Cited by 356 · see citing works
Reactive Oxygen Species: Involvement in T Cell Signaling and Metabolism
Franchina, D. G., Dostert, C., & Brenner, D. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.01.005 · Cited by 322 · see citing works
Fernández, D., Bonilla, E., Mirza, N., Niland, B. P., & Perl, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22085 · Cited by 321 · see citing works
T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy
Sharabi, A., & Tsokos, G. C. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0356-x · Cited by 292 · see citing works
Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice
Wruck, C. J., Fragoulis, A., Gurzynski, A., Brandenburg, L., Kan, Y. W., Chan, K., Hassenpflug, J., Freitag‐Wolf, S., Varoga, D. J., Lippross, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132720 · Cited by 283 · see citing works
Caielli, S., Veiga, D. T., Balasubramanian, P., Athale, S., Domic, B., Murat, E., Banchereau, R., Xu, Z., Chandra, M., Chung, C.-H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0254-9 · Cited by 263 · see citing works
Ma, Q., Battelli, L. A., & Hubbs, A. F. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051113 · Cited by 246 · see citing works
Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function
Kurniawan, H., Franchina, D. G., Guerra, L., Bonetti, L., Soriano‐Baguet, L., Grusdat, M., Schlicker, L., Hunewald, O. E., Dostert, C., Merz, M. P., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.004 · Cited by 245 · see citing works
Jiang, T., Tian, F., Zheng, H., Whitman, S. A., Lin, Y., Zhang, Z., Zhang, N., & Zhang, D. D. (2013) · Kidney International · doi:10.1038/ki.2013.343 · Cited by 233 · see citing works
Aladaileh, S. H., Abukhalil, M. H., Saghir, S. A. M., Hanieh, H., Alfwuaires, M. A., Almaiman, A. A., Bin-Jumah, M. N., & Mahmoud, A. M. (2019) · Biomolecules · doi:10.3390/biom9080346 · Cited by 213 · see citing works
Mougiakakos, D., Johansson, C. C., & Kiessling, R. W. (2008) · Blood · doi:10.1182/blood-2008-09-181040 · Cited by 195 · see citing works
Hoffmann, M. H., & Griffiths, H. R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.016 · Cited by 187 · see citing works
Oxidatively modified autoantigens in autoimmune diseases
Kurien, B. T., Hensley, K., Bachmann, M. P., & Scofield, R. H. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.020 · Cited by 186 · see citing works
Jacob, C. O., Eisenstein, M., Dinauer, M. C., Ming, W., Liu, Q., John, S. K., Quismorio, F. P., Reiff, A. O., Myones, B. L., Kaufman, K. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113251108 · Cited by 184 · see citing works
A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases
Zhao, J. H., Ma, J., Deng, Y., Kelly, J. A., Kim, K.-W., Bang, S., Lee, H., Li, Q., Wakeland, E. K., Qiu, R., et al. (2017) · Nature Genetics · doi:10.1038/ng.3782 · Cited by 184 · see citing works
Reddy, N. M., Kleeberger, S. R., Kensler, T. W., Yamamoto, M. P., Hassoun, P. M., & Reddy, S. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804248 · Cited by 159 · see citing works
Osburn, W. O., Yates, M. S., Dolan, P. D., Chen, S., Liby, K. T., Sporn, M. B., Taguchi, K., Yamamoto, M. P., & Kensler, T. W. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn079 · Cited by 158 · see citing works
Mahmoud, A. M., Hussein, O. E., Hozayen, W. G., & El-Twab, S. M. A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.04.009 · Cited by 154 · see citing works
Olsson, L. M., Johansson, Å. C. M., Gullstrand, B., Jönsen, A., Saevarsdóttir, S., Rönnblom, L., Leonard, D., Wetterö, J., Sjöwall, C., Svenungsson, E., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211287 · Cited by 142 · see citing works
Identification of polymorphisms in the promoter region of the human NRF2 gene
Yamamoto, T., Yoh, K., Kobayashi, A., Ishii, Y., Kure, S., Kôyama, A., Sakamoto, T., Sekizawa, K., Motohashi, H., & Yamamoto, M. P. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.112 · Cited by 137 · see citing works
Alam, M. M., Okazaki, K., Nguyen, L. T. T., Ota, N., Kitamura, H., Murakami, S., Shima, H., Igarashi, K., Sekine, H., & Motohashi, H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773960 · Cited by 122 · see citing works
Glutathione Primes T Cell Metabolism for Inflammation
Mak, T. W., Grusdat, M., Duncan, G. S., Dostert, C., Nonnenmacher, Y., Cox, M. A., Binsfeld, C., Hao, Z., Brüstle, A., Itsumi, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.009 · Cited by 118 · see citing works
T Lymphocyte–Specific Activation of Nrf2 Protects from AKI
Noel, S., Martina, M. N., Bandapalle, S., Racusen, L. C., Potteti, H. R., Hamad, A. R. A., Reddy, S. P., & Rabb, H. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014100978 · Cited by 105 · see citing works
Kratschmar, D. V., Calabrese, D., Walsh, J., Lister, A., Birk, J., Appenzeller‐Herzog, C., Moulin, P., Goldring, C. E., & Odermatt, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036774 · Cited by 94 · see citing works
Shen, H., Wu, N., Wang, Y., Zhao, H., Zhang, L., Li, T., & Zhao, M. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.02.020 · Cited by 92 · see citing works
Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice
Suzuki, T., Murakami, S., Biswal, S. S., Sakaguchi, S., Harigae, H., Yamamoto, M. P., & Motohashi, H. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00063-17 · Cited by 88 · see citing works
Metabolic abnormalities and oxidative stress in lupus
Lightfoot, Y. L., Blanco, L. P., & Kaplan, M. J. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000413 · Cited by 85 · see citing works
Characterization of the metabolic phenotype of chronically activated lymphocytes
Wahl, D., Petersen, B., Warner, R. E., Richardson, B. C., Glick, G. D., & Opipari, A. (2010) · Lupus · doi:10.1177/0961203310373109 · Cited by 82 · see citing works
Córdova, E., Velázquez‐Cruz, R., Centeno-Cruz, F., Baca, V., & Orozco, L. (2010) · Lupus · doi:10.1177/0961203310367917 · Cited by 67 · see citing works
Morzadec, C., Macoch, M., Sparfel, L., Kerdine‐Römer, S., Fardel, O., & Vernhet, L. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.006 · Cited by 67 · see citing works
Perl, A. (2009) · Autoimmunity · doi:10.3109/08916930903374774 · Cited by 66 · see citing works
Lozovoy, M. A. B., Simão, A. C., Panis, C., Rotter, M., Reiche, E. M. V., Morimoto, H., Lavado, E. L., Cecchini, R., & Dichi, I. (2011) · Lupus · doi:10.1177/0961203311411350 · Cited by 59 · see citing works
T Cell Rewiring in Differentiation and Disease
Krishnan, S. K., Färber, D. L., & Tsokos, G. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3325 · Cited by 58 · see citing works
Jacob, C. O., Yu, N., Yoo, D., Perez‐Zapata, L. J., Barbu, E. A., Kaplan, M. J., Purmalek, M. M., Pingel, J. T., Idol, R. A., & Dinauer, M. C. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40141 · Cited by 58 · see citing works
Zhao, M., Chen, H., Ding, Q., Xu, X., Yu, B., & Huang, Z. (2016) · Scientific Reports · doi:10.1038/srep38619 · Cited by 57 · see citing works
Ohl, K., Fragoulis, A., Klemm, P., Baumeister, J., Klock, W., Verjans, E., Böll, S., Möllmann, J., Lehrke, M., Costa, I. G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01552 · Cited by 55 · see citing works
Self-citationPerl, A. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32832efe6b · Cited by 51 · see citing works
PGK1 depletion activates Nrf2 signaling to protect human osteoblasts from dexamethasone
Liang, J., Zhang, X.-Y., Zhen, Y.-F., Chen, C., Tan, H., Hu, J., & Tan, M.-S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2112-1 · Cited by 50 · see citing works
Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy
Bona, N., Pezzarini, E., Balbi, B., Daniele, S. M., Rossi, M. F., Monje, A. L., Basiglio, C. L., Pelusa, H. F., & Arriaga, S. M. M. (2020) · Lupus · doi:10.1177/0961203320904784 · Cited by 49 · see citing works
Reactive oxygen homeostasis – the balance for preventing autoimmunity
Kienhöfer, D., Boeltz, S., & Hoffmann, M. H. (2016) · Lupus · doi:10.1177/0961203316640919 · Cited by 42 · see citing works
Nrf2 regulates CD4+ T cell–induced acute graft-versus-host disease in mice
Tsai, J. J.-Y., Velardi, E., Shono, Y., Argyropoulos, K. V., Holland, A. M., Smith, O. M., Yim, N. L., Rao, U. K., Kreines, F. M., Lieberman, S. R., et al. (2018) · Blood · doi:10.1182/blood-2017-10-812941 · Cited by 42 · see citing works
Elloumi, N., Mansour, R. B., Marzouk, S., Mseddi, M., Fakhfakh, R., Gargouri, B., Masmoudi, H., & Lassoued, S. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.01.018 · Cited by 41 · see citing works
Pyaram, K., Kumar, A., Kim, Y., Noel, S., Reddy, S. P., Rabb, H., & Chang, C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.052 · Cited by 38 · see citing works
Vukelic, M., Kono, M., & Tsokos, G. C. (2020) · Immunometabolism · doi:10.20900/immunometab20200009 · Cited by 36 · see citing works
Nrf2 deficiency improves autoimmune nephritis caused by the fas mutation lpr
Morito, N., Yoh, K., Hirayama, A., Itoh, K., Nose, M., Kôyama, A., Yamamoto, M. P., & Takahashi, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00565.x · Cited by 32 · see citing works
Immune cell metabolism in autoimmunity
Teng, X., Li, W., Cornaby, C., & Morel, L. M. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13277 · Cited by 32 · see citing works
Kuhn, A., Landmann, A., Patsinakidis, N., Ruland, V., Nozinic, S., Ortiz, A. M. P., Sauerland, C., Luger, T., Tsianakas, A., & Bonsmann, G. (2016) · Lupus · doi:10.1177/0961203316644335 · Cited by 30 · see citing works
Electrophiles against (Skin) Diseases: More Than Nrf2
Hennig, P., Fenini, G., Filippo, M. D., & Beer, H. (2020) · Biomolecules · doi:10.3390/biom10020271 · Cited by 30 · see citing works
Caught in the cROSsfire: GSH Controls T Cell Metabolic Reprogramming
Geltink, R. I. K., O’Sullivan, D., & Pearce, E. L. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.022 · Cited by 29 · see citing works
Klemm, P., Rajendiran, A., Fragoulis, A., Wruck, C. J., Schippers, A., Wagner, N., Bopp, T., Tenbrock, K., & Ohl, K. (2019) · European Journal of Immunology · doi:10.1002/eji.201948285 · Cited by 28 · see citing works
Self-citationHan, S., Zhuang, H., Lee, P. Y., Li, M., Yang, L., Nigrovic, P. A., & Reeves, W. H. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41383 · Cited by 28 · see citing works
Singlet oxygen species and systemic lupus erythematosus: a brief review
Ahmad, R., & Ahsan, H. (2019) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2019.1616555 · Cited by 26 · see citing works
Metabolic control of T cells in autoimmunity
Kono, M., Yoshida, N., & Tsokos, G. C. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000685 · Cited by 23 · see citing works
Tapia, E., García‐Arroyo, F. E., Silverio, O., Rodriguez-Alcocer, A. N., Jiménez-Flores, A. B., Cristóbal, M., Arellano, A., Soto, V., Osorio‐Alonso, H., Molina‐Jijón, E., et al. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1174776 · Cited by 22 · see citing works
Rokutan, K., Hosokawa, T., Nakamura, K., Koyama, K., Aoike, A., & Kawai, K. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234660 · Cited by 21 · see citing works
Alternations of salivary antioxidant enzymes in systemic lupus erythematosus
Zaieni, S., Derakhshan, Z., & Sariri, R. (2015) · Lupus · doi:10.1177/0961203315593170 · Cited by 19 · see citing works
Activation of Nrf2-ARE signaling mitigates cyclophosphamide-induced myelosuppression
Que, L., He, L., Yu, C., Yin, W., Ma, L., Cao, B., & Yu, S. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.09.003 · Cited by 18 · see citing works
Sam, N. B., Li, B., Leng, R., Pan, H., & Dong-qing, Y. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0034 · Cited by 18 · see citing works
Patent Review (2017–2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases
Chartoumpekis, D. V., Fu, C., Ziros, P. G., & Sykiotis, G. P. (2020) · Antioxidants · doi:10.3390/antiox9111138 · Cited by 18 · see citing works
Gautam, P., Kaur, G., Tandon, A., Sharma, A., & Bhatnagar, A. (2020) · Lupus · doi:10.1177/0961203320950022 · Cited by 16 · see citing works
Tandon, A., Anupam, K., Kaushal, J., Gautam, P., Sharma, A., & Bhatnagar, A. (2020) · Lupus · doi:10.1177/0961203320959441 · Cited by 15 · see citing works
Serrya, M. S., & Zaghloul, M. S. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00055-4 · Cited by 10 · see citing works
Karl, F., Stoll, A., Loschinski, R., Böttcher, M., Baur, R., Jacobs, B., Völkl, S., Jitschin, R., Rösler, W., Mackensen, A., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0956-0 · Cited by 9 · see citing works
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Phelps, C. M., Willis, N. B., Duan, T., Lee, A. H., Zhang, Y., Rodriguez J, D. M., Pandey, S. P., Laughlin, C. R., Rosen, A. B. I., McPherson, A. C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.018 · Cited by 91 · see citing works
Arreola‐Diaz, R., Majluf‐Cruz, A., Sanchez-Torres, L., & Hernández‐Juárez, J. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221088576 · Cited by 76 · see citing works
García-Llorens, G., Ouardi, M. E., & Valls‐Bellés, V. (2025) · Applied Sciences · doi:10.3390/app151810191 · Cited by 66 · see citing works
Mitochondria as a key player in systemic lupus erythematosus
Quintero-González, D. C., Muñoz-Urbano, M., & Vásquez, G. M. (2022) · Autoimmunity · doi:10.1080/08916934.2022.2112181 · Cited by 31 · see citing works
mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus
Zhao, X., Wang, S., Wang, S., Xie, J., & Cui, D. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109153 · Cited by 30 · see citing works
Yao, M., Huang, X., Guo, Y., Zhao, J. V., & Liu, Z. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28570 · Cited by 27 · see citing works
Rutin alleviates lupus nephritis by inhibiting T cell oxidative stress through PPARγ
Yi, T., Zhang, W., Hua, Y., Xin, X., Wu, Z., Li, Y., Wen, C., Fan, Y., Ji, J., & Xu, L. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.110972 · Cited by 25 · see citing works
Du, L., Feng, Y., Wang, C., Shi, X., Wen, C., He, Z., & Zhang, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115643 · Cited by 22 · see citing works
Teng, X., Brown, J., & Morel, L. M. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0070 · Cited by 21 · see citing works
Sun, X., Huang, X., Sun, X., Chen, S., Zhang, Z., Yu, Y., & Zhang, P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.909797 · Cited by 21 · see citing works
The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
Barati, M. T., & Caster, D. J. (2022) · Metabolites · doi:10.3390/metabo12020151 · Cited by 20 · see citing works
T Cell Nrf2/Keap1 Gene Editing Using CRISPR/Cas9 and Experimental Kidney Ischemia-Reperfusion Injury
Kurzhagen, J. T., Noel, S., Lee, K., Sadasivam, M., Gharaie, S., Ankireddy, A., Lee, S. A., Newman-Rivera, A. M., Gong, J., Arend, L. J., et al. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0058 · Cited by 19 · see citing works
Metabolic Plasticity of Regulatory T Cells in Health and Autoimmunity
Carbone, F., Colamatteo, A., Rocca, C. L., Lepore, M. T., Russo, C., Rosa, G. D., Matarese, A., Procaccini, C., & Matarese, G. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400079 · Cited by 14 · see citing works
NRF2 Dysregulation and Therapeutic Insights Across Chronic Kidney Diseases
Lim, T. S. T., Ng, K. H., & Zhang, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157471 · Cited by 11 · see citing works
The immunology of exercise: Mechanisms, mediators, and therapeutic opportunities
Phelps, C. M., & Meisel, M. (2026) · Immunity · doi:10.1016/j.immuni.2026.04.016 · Cited by 11 · see citing works
Li, J., Guo, Q., Wei, X., Zhu, Y., Luo, M., & Luo, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1304167 · Cited by 11 · see citing works
Yudhani, R. D., Pakha, D. N., Suyatmi, S., & Irham, L. M. (2023) · Genomics & Informatics · doi:10.5808/gi.23002 · Cited by 9 · see citing works
Ateş, İ., Yılmaz, A. D., Buttari, B., Arese, M., Saso, L., & Süzen, S. (2023) · Brain Sciences · doi:10.3390/brainsci13111532 · Cited by 9 · see citing works
Wang, Q., Ye, X., Tan, S., Jiang, Q., Su, G., Pan, S., Li, H., Cao, Q., & Yang, P. (2024) · Inflammation · doi:10.1007/s10753-023-01950-y · Cited by 8 · see citing works
CD8 + T regulatory cells in lupus
Singh, R. P., Bischoff, D. S., & Hahn, B. H. (2021) · Rheumatology and Immunology Research · doi:10.2478/rir-2021-0021 · Cited by 7 · see citing works
Mechanisms underlying sex bias in oral immune‐mediated conditions, an insight
Alrashdan, M. S., Al-Rawi, N. H., Hassona, Y. M., Kawas, S. A., & Cirillo, N. (2023) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.13466 · Cited by 7 · see citing works
Lao, Z., Fang, X., Shen, S., Zhang, Y., Chen, X., Zhang, H., Bian, Y., Zhou, C., Bao, R., Xu, T., et al. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s486297 · Cited by 6 · see citing works
Serum 3-Nitrotyrosine in the Cardiovascular Disease of Patients with Systemic Lupus Erythematosus
Quevedo-Abeledo, J. C., Hernández-Díaz, M., García-González, M., Gómez-Bernal, F., Almeida-Santiago, C., Heras-Recuero, E., de Vera-González, A., Delgado, A. G., Abreu-González, P., Segura, B. T., et al. (2025) · Antioxidants · doi:10.3390/antiox14060739 · Cited by 3 · see citing works
Glycation end-products specific auto-antibodies in Systemic Lupus Erythematosus
Khan, M. W. A. (2022) · Bioinformation · doi:10.6026/97320630018127 · Cited by 2 · see citing works
Hypoxia and the Hypoxia-Inducible Factors in Lymphocyte Differentiation and Function
Boothby, M. R., & Cho, S. H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_6 · Cited by 1 · see citing works
Systemic Lupus Erythematosus: Emerging Insights into Diagnosis, Treatment, and Prognosis
Kumbhare, M. R., Narkhede, H. I., Chandak, S. M., & Dukare, A. B. (2025) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0070 · Cited by 1 · see citing works
(2022) · Cancer Cell Research · doi:10.54762/ccr2022.877-885 · Cited by 1 · see citing works
Nowling, T. K., & Oates, J. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93232-5.00028-9
Gizatullina, R. R., Mehrazin, O., Khotbehsara, N. M., Bazargaliyev, Y., Zhamankulova, D. G., & Tyurin, A. V. (2025) · Медицинский журнал Западного Казахстана · doi:10.4103/wkmj.wkmj_3_26
Hu, L., Pan, S., Wang, J., Mei, S., Pan, H., & Chang, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1764448
NRF2: sensing stress, shaping immunity - keeping inflammation quiet and antigens out of sight
Benatzy, Y., & Brüne, B. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1974746
- Authors
- Ohl, K., & Tenbrock, K.
- Affiliations
- RWTH Aachen University (DE)
- Corresponding author
- Tenbrock, Klaus
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-04-23
- Volume
- 12
- Pages
- 633845-633845
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC8102865
- OpenAlex
- W3159351347
- Cited by
- 31
- References
- 78
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 8 · 2021: 2
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- RWTH Publications (RWTH Aachen) (submittedVersion, other-oa)
- RWTH Publications (RWTH Aachen)
- Funders
- Deutsche Forschungsgemeinschaft (252/2-1, OH 252/2‐1)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- oxidative stress, systemic lupus erythematosus, T cells, Nrf2, Keap1, Nrf2/Keap1 pathway, Th17 cells, antioxidant defense, therapeutic target
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Antioxidants, Humans, Lupus Erythematosus, Systemic, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, NF-E2-Related Factor 2, Forkhead Transcription Factors, Th17 Cells, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review